Skip to main content
Equibles
EYPT logo

EYPT · EyePoint, Inc.

Track EYPT — free Ask ALVIS about EYPT
$12.52 +0.60 (+5.03%)
Market Cap
$999.39M
Shares
83.84M

EyePoint, Inc. Earnings Call Transcripts

Every quarterly earnings call for EyePoint, Inc. (EYPT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲61.9% $11.54M −$19.43M '21 Q4 22-03-03 ▲26.9% $9.29M −$20.98M '22 Q1 22-05-04 ▲28.3% $11.56M −$19.41M '22 Q2 22-07-18 ▲10.5% $10.01M −$18.42M '22 Q3 22-11-02 ▼8.8% $10.53M −$43.45M '22 Q4 23-01-06 ▼17.3% $7.68M −$21.16M '23 Q1 23-05-03 ▼21.3% $9.11M −$22.92M '23 Q2 23-08-02 ▲51.8% $15.20M −$12.61M '23 Q3 23-11-01 ▲33.2% $14.03M −$14.10M '23 Q4 24-01-10 ▲52.1% $11.68M −$29.28M '24 Q1 24-06-26 ▼17.4% $11.59M −$41.40M '24 Q4 25-03-05 ▲109.3% $24.45M −$45.20M '25 Q1 25-05-07 ▼43.7% $5.33M −$59.43M '25 Q2 25-08-06 ▼90.8% $966,000 −$59.73M '25 Q3 25-11-05 ▼94.7% $619,000 −$67.61M '25 Q4 26-03-04 LATEST ▼97.2% $696,000 −$84.83M '26 Q1 26-05-06
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
EyePoint, Inc. Q1 FY2026 Earnings Call
Confident tone DuraVue Phase 3 wet AMD readouts (Lugano and Lucia) DME Phase 3 program (COMO and CAPRI) enrollment Multi-mechanism of action (VEGF, PDGF, IL-6/JAK1)
Revenue
$696,000
▼ 97.2% YoY
Diluted EPS
$-0.99
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-04
EyePoint, Inc. Q4 FY2025 Earnings Call
Confident tone DuraVu wet AMD Phase 3 (Lugano/LUCIA) DuraVu DME Phase 3 (COMO/CAPRI) Differentiated mechanism of action
Revenue
$619,000*
▼ 94.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
EyePoint, Inc. Q3 FY2025 Earnings Call
Confident tone DURAVYU in wet AMD Phase III (LUGANO/LUCIA) DURAVYU in DME Phase III (COMO/CAPRI) Vorolanib multi-mechanism (VEGF, PDGF, IL-6)
Revenue
$966,000
▼ 90.8% YoY
Diluted EPS
$-0.85
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
EyePoint, Inc. Q2 FY2025 Earnings Call
Confident tone DURAVYU Phase III trials in wet-AMD (LUGANO and LUCIA) DME (VERONA trial) pipeline expansion Competitive landscape and first-mover advantage
Revenue
$5.33M
▼ 43.7% YoY
Diluted EPS
$-0.85
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
EyePoint, Inc. Q1 FY2025 Earnings Call
Confident tone DURAVYU Phase 3 Wet AMD Trials (LUGANO/LUCIA) Diabetic Macular Edema (DME) Program Regulatory and Trial Design
Revenue
$24.45M
▲ 109.3% YoY
Diluted EPS
$-0.65
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-05
EyePoint, Inc. Q4 FY2024 Earnings Call
Confident tone DURAVYU Phase 3 wet AMD trials (LUGANO and LUCIA) DURAVYU Phase 2 VERONA trial in DME De-prioritized razuprotafib program
Revenue
$11.59M*
▼ 17.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q1
2024-06-26
EyePoint, Inc. Q1 FY2024 Earnings Call
Revenue
$11.68M
▲ 52.1% YoY
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-10
EyePoint, Inc. Q4 FY2023 Earnings Call
Confident tone EYP-1901 pipeline progress NPDR / DME indications DAVIO 2 Phase 2 results
Revenue
$14.03M*
▲ 33.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
EyePoint, Inc. Q3 FY2023 Earnings Call
Revenue
$15.20M
▲ 51.8% YoY
Diluted EPS
$-0.33
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
EyePoint, Inc. Q2 FY2023 Earnings Call
Revenue
$9.11M
▼ 21.3% YoY
Diluted EPS
$-0.61
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
EyePoint, Inc. Q1 FY2023 Earnings Call
Revenue
$7.68M
▼ 17.3% YoY
Diluted EPS
$-0.56
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-06
EyePoint, Inc. Q4 FY2022 Earnings Call
Revenue
$10.53M*
▼ 8.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
EyePoint, Inc. Q3 FY2022 Earnings Call
Revenue
$10.01M
▲ 10.5% YoY
Diluted EPS
$-0.49
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-18
EyePoint, Inc. Q2 FY2022 Earnings Call
Revenue
$11.56M
▲ 28.3% YoY
Diluted EPS
$-0.52
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
EyePoint, Inc. Q1 FY2022 Earnings Call
Revenue
$9.29M
▲ 26.9% YoY
Diluted EPS
$-0.56
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
EyePoint, Inc. Q4 FY2021 Earnings Call
Revenue
$11.54M*
▲ 61.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
EyePoint, Inc. Q3 FY2021 Earnings Call
Revenue
$9.06M
▼ 42.3% YoY
Diluted EPS
$-0.58
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
EyePoint, Inc. Q2 FY2021 Earnings Call
Revenue
$9.01M
▲ 118.7% YoY
Diluted EPS
$-0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
EyePoint, Inc. Q1 FY2021 Earnings Call
Revenue
$7.32M
▼ 2.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
EyePoint, Inc. Q4 FY2020 Earnings Call
Revenue
$7.13M*
▼ 17.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-07
EyePoint, Inc. Q3 FY2020 Earnings Call
Revenue
$15.70M
▲ 525.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
EyePoint, Inc. Q2 FY2020 Earnings Call
Revenue
$4.12M
▼ 42.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
EyePoint, Inc. Q1 FY2020 Earnings Call
Revenue
$7.49M
▲ 272.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
EyePoint, Inc. Q4 FY2019 Earnings Call
Revenue
$8.63M
▲ 253.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–26 of 26 earnings calls
Key facts CIK 1314102 CUSIP 30233G209 13F (30d) 25 filings 25 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)